WeightWatchers’ bold gamble: CEO Sistani fuses AI, GLP-1 drugs, and 60 years of trust into a revolutionary health tech platform to conquer the $377B weight loss market.
Source link
Inside WeightWatchers’ Bold Pivot To Dominate The Ozempic Era
![Inside WeightWatchers’ Bold Pivot To Dominate The Ozempic Era Inside WeightWatchers’ Bold Pivot To Dominate The Ozempic Era](https://i0.wp.com/imageio.forbes.com/specials-images/imageserve/66c34782d3fe1ea20faf97eb/0x0.jpg?format=jpg&crop=1710,693,x0,y99,safe&height=900&width=1600&fit=bounds&w=1024&resize=1024,1024&ssl=1)
WeightWatchers’ bold gamble: CEO Sistani fuses AI, GLP-1 drugs, and 60 years of trust into a revolutionary health tech platform to conquer the $377B weight loss market.
Source link